Enliven Therapeutics Inc (NAS:ELVN)
$ 57.89 -0.84 (-1.43%) Market Cap: 4.24 Bil Enterprise Value: 3.35 Bil PE Ratio: 0 PB Ratio: 4.28 GF Score: 31/100

Enliven Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 03:30 PM GMT
Release Date Price: $28.75 (-2.54%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ELVN.OQ - Enliven Therapeutics Inc
Enliven Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 03:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome once again to TD Cowan's forty-sixth annual Healthcare Conference. I'm Phil Nado, one of the biotech analysts here at Cowan, and it's my pleasure to moderate a fireside chat with Enliven. We have with us Rick Fear, CFO, and Ben Holt, sorry, Rick Fear, CEO Ben Holt, CFO. Guys, I'll kick it to you to begin. Just a state of the company, question. What is the current state of Enliven, Biggest challenges, biggest strengths, and what will Enliven do to create shareholder value?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Awesome. Thanks
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot